154. Ward JR, Williams HJ, Egger MJ, Reading JC, Boyce E, Altz-Smith M, Samuelson CO Jr,
Willkens RF, Solsky MA, Hayes SP, Blocka KL, Weinstein A, Meenan RF, Guttadauria M,
Kaplan SB, Klippel J (1983) Arthritis Rheumatism 26:1303–1315
155. Rosenberg B, Vancamp L, Krigas T (1965) Nature 205:698–699
156. Wenzel M, Bertrand B, Eymin M-J, Comte V, Harvey JA, Richard P, Groessl M, Zava O,
Amrouche H, Harvey PD, Le Gendre P, Picquet M, Casini A (2011) Inorg Chem
50:9472–9480
157. Gonza ´lez-Pantoja JF, Stern M, Jarzecki AA, Royo E, Robles-Escajeda E, Varela-Ramı ´rez A,
Aguilera RJ, Contel M (2011) Inorg Chem 50:11099–11110
158. Ferna ´ndez-Gallardo J, Elie BT, Sulzmaier FJ, Sanau ´ M, Ramos JW, Contel M (2014)
Organometallics 33:6669–6681
159. Ferna ´ndez-Gallardo J, Elie BT, Sadhukha T, Prabha S, Sanau ´ M, Rotenberg SA, Ramos JW,
Contel M (2015) Chem Sci 6:5269–5283
160. Korfel A, Scheulen ME, Schmoll HJ, Gru ¨ndel O, Harstrick A, Knoche M, Fels LM,
Skorzec M, Bach F, Baumgart J, Sass G, Seeber S, Thiel E, Berdel WE (1998) Clin Cancer
Res 4:2701–2708
161. Abeysinghe PM, Harding MM (2007) Dalton Trans 3474–3482
162. Olszewski U, Hamilton G (2010) Anticancer Agents Med Chem 10:302–311
163. Lu ¨mmen G, Sperling H, Luboldt H, Otto T, Ru ¨bben H (1998) Cancer Chemother Pharmacol
42:415–417
164. Strohfeldta K, Tacke M (2008) Chem Soc Rev 37:1174–1187
165. Tshuva EY, Ashenhurst JA (2009) Eur J Inorg Chem 2203–2218
166. Muhammad N, Guo Z (2014) Curr Opin Chem Biol 19:144–153
167. Klein AV, Hambley TW (2014) In: Storr T (ed) Platinum-based anticancer agents in ligand
design in medicinal inorganic chemistry. Wiley, Chichester, pp 9–10
186
E. Bodio et al.
Willkens RF, Solsky MA, Hayes SP, Blocka KL, Weinstein A, Meenan RF, Guttadauria M,
Kaplan SB, Klippel J (1983) Arthritis Rheumatism 26:1303–1315
155. Rosenberg B, Vancamp L, Krigas T (1965) Nature 205:698–699
156. Wenzel M, Bertrand B, Eymin M-J, Comte V, Harvey JA, Richard P, Groessl M, Zava O,
Amrouche H, Harvey PD, Le Gendre P, Picquet M, Casini A (2011) Inorg Chem
50:9472–9480
157. Gonza ´lez-Pantoja JF, Stern M, Jarzecki AA, Royo E, Robles-Escajeda E, Varela-Ramı ´rez A,
Aguilera RJ, Contel M (2011) Inorg Chem 50:11099–11110
158. Ferna ´ndez-Gallardo J, Elie BT, Sulzmaier FJ, Sanau ´ M, Ramos JW, Contel M (2014)
Organometallics 33:6669–6681
159. Ferna ´ndez-Gallardo J, Elie BT, Sadhukha T, Prabha S, Sanau ´ M, Rotenberg SA, Ramos JW,
Contel M (2015) Chem Sci 6:5269–5283
160. Korfel A, Scheulen ME, Schmoll HJ, Gru ¨ndel O, Harstrick A, Knoche M, Fels LM,
Skorzec M, Bach F, Baumgart J, Sass G, Seeber S, Thiel E, Berdel WE (1998) Clin Cancer
Res 4:2701–2708
161. Abeysinghe PM, Harding MM (2007) Dalton Trans 3474–3482
162. Olszewski U, Hamilton G (2010) Anticancer Agents Med Chem 10:302–311
163. Lu ¨mmen G, Sperling H, Luboldt H, Otto T, Ru ¨bben H (1998) Cancer Chemother Pharmacol
42:415–417
164. Strohfeldta K, Tacke M (2008) Chem Soc Rev 37:1174–1187
165. Tshuva EY, Ashenhurst JA (2009) Eur J Inorg Chem 2203–2218
166. Muhammad N, Guo Z (2014) Curr Opin Chem Biol 19:144–153
167. Klein AV, Hambley TW (2014) In: Storr T (ed) Platinum-based anticancer agents in ligand
design in medicinal inorganic chemistry. Wiley, Chichester, pp 9–10
186
E. Bodio et al.